Researchers have identified structural 'footprints' that allow certain virus vectors reach the brain easily.
UC Berkeley researchers report they have successfully used CRISPR-Cas9 gene editing to delay symptoms and extend lifespan in mouse models of ALS.
Max Planck researchers announce they have developed a new tool that can assist with precise genome editing in neurons.
A new study in Molecular Therapy reveals gene immunotherapy is able to reverse symptoms of Multiple Sclerosis, and even prevent the disease from appearing in mice.
A new study reports researchers have successfully modified a virus to be able to enter a mouse brain via the bloodstream and deliver genes to central nervous system cells.
